News Desk, AnyTV, New Delhi
Published by: Shiv Sharan Shukla
Updated Mon, 07 Mar 2022 11:39 PM IST
Summary
Covaxin, the corona vaccine made by Bharat Biotech, has got approval for clinical trials on adults in the US and Canada. Bharat Biotech and its American partnership company Oguen have expressed happiness over this decision of the FDA.
Covaxin, the corona vaccine made by Bharat Biotech, has got approval for clinical trials on adults in the US and Canada. Covaccine has been approved by the US Food and Drug Administration (FDA).
Bharat Biotech and its American partnership company Oguen expressed their happiness over the FDA’s decision and reiterated their commitment to the people. According to a statement issued by Bharat Biotech, the FDA has approved Oguen’s Phase 2/3 test drug application for Covaxin. Oguen will continue to work with the FDA regarding the regulatory process for Covaxin’s use on children. Bharat Biotech had claimed some time back that it would get approval in the US as well.
Let us tell you that Oguen US is a biopharma company, which is working with Hyderabad-based Bharat Biotech to make Covaxin. Occugen recently acquired exclusive rights to sell the vaccine in Canada.
Expansion
Covaxin, the corona vaccine made by Bharat Biotech, has got approval for clinical trials on adults in the US and Canada. Covaccine has been approved by the US Food and Drug Administration (FDA).
Bharat Biotech and its American partnership company Oguen expressed their happiness over the FDA’s decision and reiterated their commitment to the people. According to a statement issued by Bharat Biotech, the FDA has approved Oguen’s Phase 2/3 test drug application for Covaxin. Oguen will continue to work with the FDA regarding the regulatory process for Covaxin’s use on children. Bharat Biotech had claimed some time back that it would get approval in the US as well.
Let us tell you that Oguen US is a biopharma company, which is working with Hyderabad-based Bharat Biotech to make Covaxin. Occugen recently acquired exclusive rights to sell the vaccine in Canada.